DCM
ABBV icon

DAFNA Capital Management’s AbbVie ABBV Stock Holding History

DAFNA Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-76,331
Closed -$4.73M – 75
2016
Q2 		$4.73M Sell
76,331
-40,250
-35% -$2.45M 3.75% 5
2016
Q1 		$6.66M Hold
116,581
– – 5.74% 2
2015
Q4 		$6.91M Hold
116,581
– – 6.16% 3
2015
Q3 		$6.34M Hold
116,581
– – 6.29% 2
2015
Q2 		$7.83M Buy
+116,581
New +$7.61M 6.62% 2

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

DAFNA Capital Management's ABBV Position: Q3 2016 in Review

DAFNA Capital Management sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 76,331 shares — an estimated $4.73M sold.

DAFNA Capital Management first reported a position in ABBV in Q2 2015 and held it in 5 quarters. The position peaked at $7.83M in Q2 2015. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • DAFNA Capital Management reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
  • DAFNA Capital Management sold 76,331 AbbVie shares in Q3 2016, an estimated $4.73M.
  • DAFNA Capital Management first reported a position in AbbVie in Q2 2015 and held it in 5 quarters.
  • DAFNA Capital Management's AbbVie position peaked at $7.83M in Q2 2015.
  • 1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on DAFNA Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.